Backed by $4.6T in assets, we harness our active edge to deliver timely ideas and actionable insights that empower investors to achieve what matters most.

Eye on the Market: Coronavirus (COVID-19) research
Michael Cembalest presents his latest research on COVID-19, the U.S. election and other current events causing market volatility.